APA (7th ed.) Citation

Rossum, A. v., & Marmé, F. (2017). BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial. Breast cancer research and treatment, 166(3), . https://doi.org/10.1007/s10549-017-4444-9

Chicago Style (17th ed.) Citation

Rossum, Annelot van, and Frederik Marmé. "BRCA1-like Profile Is Not Significantly Associated with Survival Benefit of Non-myeloablative Intensified Chemotherapy in the GAIN Randomized Controlled Trial." Breast Cancer Research and Treatment 166, no. 3 (2017). https://doi.org/10.1007/s10549-017-4444-9.

MLA (9th ed.) Citation

Rossum, Annelot van, and Frederik Marmé. "BRCA1-like Profile Is Not Significantly Associated with Survival Benefit of Non-myeloablative Intensified Chemotherapy in the GAIN Randomized Controlled Trial." Breast Cancer Research and Treatment, vol. 166, no. 3, 2017, https://doi.org/10.1007/s10549-017-4444-9.